Get complete information related to latest Vaccines Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Vaccines Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Vaccines Tenders.
Tender For supply of supply of medical items and reagents : : - proposed walk in cooler room size , frost free double door convertible refrigerator smart digital display , vaccine carrier with 4 nos of ice packs , id screen brucellosis serum indirect multi species , id screen fmd nsp competition , id screen pprs indirect , id screen ppr competition , id screen classical swine fever e2 competition , id screen ppr antigen capture elisa , syringe , needle , absorbent cotton , dr clean isopropyl alcohol ip 70 percentage , surgical mask 3point ply , gloves
Tender For corrigendum : tender for the supply of 8 drugs for various health institutions across karnataka under annual indent 2025-26 - rabies antiserum ip-(equine) 300 iu/ml 1x5ml vial, diphtheria plus tetanus vaccine (adsorbed) for adults and adolescents ip each 0.5 ml contains diphtheria toxoid 2iu tetanus toxoid 5lf to 25 lf or 20 iu absorbed on aluminum phosphate 1x0.5 ml vial/ampoule, anti-d immunoglobulin ip 300mcg 1x1 ml vial, iv amino acid infusion (iv fluid bottle contains essential amino acid, glycine, sorbetole) 1x200 ml bottle, sodium chloride and dextrose injection ip (sodium chloride 0.9% and dextrose 5% ) 1x500 ml bottle, oral rehydration powder 20.5 gm who formula 1x1 sachet, dextrose injection ip 25% w/v 1x100 ml bottle, compound sodium lactate injection ip (ringer-lactate solution ) 1x500 ml bottle
Tender For corrigendum : supply of drugs and pharmaceuticals - d cfa re 53 aspirin soluble 350 mg tab , d cfa re 53 morphine 15 mg 1 ml inj , d cfa re 53 sumatriptan nasal spray 20 mg 10 metered doses , d cfa re 53 ampicillin ip 250 mg cap , d cfa re 53 artesunate 25 mg sulphadoxine 250 mg pyrimethamine 12 dot 5 mg tab , d cfa re 53 rifampicin 450 mg isoniazid 300 mg combination captab , d cfa re 53 isoniazid 100mg with pyridoxine 5mg tab , d cfa re 53 cefaclor 250 mg cap , d cfa re 53 netilmicin sulphate 200 mg2 ml inj , d cfa re 53 levosalbutamol 1mg5ml bott of 100ml , d cfa re 53 mr vaccine measles rubella live attenuated , d cfa re 53 midazolam 5mg 1ml inj , d cfa re 53 desonide 0 dot 05 bott of 30 ml , d cfa re 53 telmisartan 40 mg hydrochlorothiazide 12 dot 5 mg tab , d cfa re 53 rivaroxaban 10 mg tab , d cfa re 53 tacrolimus 0 dot 5mg prolonged release cap , d cfa re 53 cefixime syp 50 mg5ml bott of 30 ml , d cfa re 53 levosalbutamol 1 dot 25 mg ipratropium 500 mcg in 2 dot 5 ml respule
Tender For re-tender for the supply of hepatitis-b vaccines for nvhcp programme under nhm committed budget fy 2025-26 - hepatitis b vaccines ip 1x1ml each 1ml should consists of 20mcg of purified hepatitis b surface antigen
Tender For corrigendum : supply of sch i (supply of injections & sera vaccines) - sch i (supply of injections & sera vaccines), inj. b complex for prophylactic use vit. c 150 mg vit. b 12 2500 mcg folic acid 0.7 mg niacinamide 12 mg, inj. b complex for therapeutic use each ml contain vit a 1000 iu cholecalciferol 100 iu alphatochopherol acetate 0.5 mg. thiamine 5 mg. pyridoxine 0.5 mg. nicotinamide 10 mg. ascorbic acid 50 mg. d-panthenol 2.5 mg., inj. calcium gluconate 10% iv use., inj. desferroxamine 500 mg, inj. digoxin 0.5 mg iv use, inj. diltiazem 5 mg/ml, inj. fluconazole 200 mg. in plastic bottle, inj. fluorescein sodium (20%), inj. hydralazine 20 mg. iv, inj. hyaluronidase 1500 iu, inj. insulin plain (purified human) 40 units/ml sc/iv use (insulin plain and insulin nph/ lente should be of the same manufacturer and their rate will be considered as a unit.), inj.insulin nph/isophane40 iu (highly purified bovine porcine isophane insulin susp 40 i.u./ml nph insulin (or neutral protamine hagedorn)., inj. isoxsuprine hcl 10 mg/ml., intravenous injection of n (2)-l alanyl-l glutamine 20%, solution 50 ml, iv lipid 20% for neo-natal use., inj.lorazepam 2 mg/ml im/iv use., inj. l-ornithine l-aspartate 5 gm, inj. n-butyl cyanoacrylate 0.5 gm., inj. methylene blue 10 mg/ml, inj. metoprolol 5mg, nitroglycerine lingual spray in ready to use formulation. each spray should deliver 0.35 to 0.4 mg/spray 60-70 lit/spray., inj. phenobarbitone sodium 200 mg iv use, inj. protamine sulphate 1% iv use, inj. somatostatin 3 mg /vial, sterile & pyrogen free water for injection i.p 5ml, inj.sterile & pyrogen free water for injections i. p. 10 ml, inj. thiamine 100 mg/ml, inj. tricort triamcinolone sodium 10 mg, inj. tuberculine p. p. d. 5 t. u./0.1 ml intradermal use., inj. vit. k 10 mg/ml (aqueous) i. m./i. v., inj. valethamate bromide 8 mg, inj. benzathine penicillin 6 lacs unit for im use, inj. benzathine penicillin 12 lacs unit im use, inj. benzyl penicillin/ penicillin g/ crystalline penicillin salt 1000000 units/bulbs i. m./i. v., inj. ofloxacin 200 mg, inj. streptomycin sulphate 0.75 gm, inj. anti d 300 microgram/dose polyclonal/monoclonal, inj. diptheria antitoxin 10000 iu, inj. hepatitis b vaccine recombinant dna technology 20 mcg/ml, inj. hib vaccine 10 mcg. haemophilus influenza type b. polysacchride conjugate vaccine. [powder to be reconstituted with 0.5 ml diluent (saline)]., inj. human rabies immunoglobulin 150 i.u./ml, inj meningococcal conjugate vaccine single dose vial containing (a, c, y & w 135) polysaccharide conjugated to diptheria toxoid protein carrier., inj. mmr vaccine (measles, mumps & rubella) single dose im or sc., inj. pneumovax (pneumococcal 23 valent vaccine), inj. polyvalent antisnake venom serum- should contain equivalent of 10 ml of purified globulins 1 ml of reconstituted serum to neutralizes 0.5 mg to 0.6 mg of dried cobra venom, 0.45 mg of dried common krait venom, 0.6 mg. of dried russells viper venom, 0.45 mg of dried saw scaled viper venom, liquid or powder form will be accepted, inj. rabies human monoclonal antibody (rdna) 40 iu/ml., inj. tetanus vaccine purified toxoid adsorbed i. p. 5 lf./0.5ml, inj. tetanus immunoglobulin (human) 250 i. u. im / intrathecal use., inj. tetanus immunoglobulin (human) 500 i. u. im / intrathecal use., inj. lignocaine 10% spray, inj. propofol 1% mct/lct fat emulsion with sodium oleate 50 ml, inj. ropivacaine hcl 0.5%, inj. 2% hydroxypropyl methyl cellulose preservative free sterile for intraocular use during cataract surgery in sterile prefilled syringe & with sterile cannula., intracameral injection lignocaine hydrochloride 1%, inj. perfluoro-n-octane liquid for intraocular use sterile, inj. pilocarpine (0.5%) nitrate/hcl sterile opthalmic solution for injection., inj. silicon oil for (polydimethyl siloxane for intraocular use) sterile viscosity 1500 mm2/s cst, inj. sodium hyaluronate 1.4%, inj. sodium hyaluronate 1.8%, inj. continuous ambulatory peritoneal d